Illumina offers industry-leading technologies designed to make genomic analysis accessible to everyone. Using powerful, proven Illumina next-generation sequencing (NGS) and microarray solutions, researchers can now read and understand genetic variations at new depths, more easily and quickly than before, enabling a wide variety of genomics applications. As a result, discoveries that were unimaginable even a few years ago are now becoming routine.
Genotyping is a popular and effective way to screen for SNPs and structural variations across the genome. Illumina technology provides the accuracy, reproducibility, and flexibility with content selection that is critical to the success of your genomics research.Learn More
Illumina technologies enable characterization of all transcriptional activity (coding and non-coding), or focusing on a select subset of RNA transcripts within a given sample for high-quality gene expression and transcriptome analysis for a broad range of sample types.Learn More
Illumina offers a broad portfolio of simple-to-use, cost-efficient epigenetic analysis tools for studying epigenetic modifications and their impact on gene regulation. By working with leading epigenomics experts, Illumina ensures its solutions meet the field's rapidly evolving needs.Learn More
Chromosome aberrations play a role in constitutional disorders and cancer. Cytogenetic analysis using proven Illumina sequencing and high-quality cytogenomic arrays can be performed on a single platform.Learn More
With its unprecedented throughput, scalability, and speed, NGS enables researchers to study biological systems at a level never before possible. Learn more about next-generation sequencing.
BeadArray high-density microarray technology increases genomic coverage for whole-genome genotyping; resolution for cytogenetics and CNV detection; and sample throughput for gene expression, DNA methylation, and focused genotyping. Learn more about BeadArray microarray technology.